About RAPT Dividend Returns
RAPT Therapeutics, Inc. (RAPT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of RAPT over the past year?
RAPT Therapeutics, Inc. (RAPT) delivered a return of 535.75% over the past year. Since RAPT does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in RAPT be worth today?
A $10,000 investment in RAPT Therapeutics, Inc. one year ago would be worth $63,575 today, representing a gain of $53,575.
Q3Does RAPT pay dividends?
RAPT Therapeutics, Inc. (RAPT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For RAPT, the total return equals the price-only return.
Q4Did RAPT beat the S&P 500?
Yes, RAPT Therapeutics, Inc. (RAPT) outperformed the S&P 500 by 520.29 percentage points over the past year. RAPT delivered a total return of 535.75%, compared to the S&P 500's 15.45%. This 520.29pp alpha means investors in RAPT earned more than a passive S&P 500 index fund.
Q5What is RAPT's worst drawdown?
RAPT Therapeutics, Inc. (RAPT) experienced a maximum drawdown of -52.08% over the past year, declining from its peak on 2025-03-25 to its trough on 2025-05-13. The stock recovered to its prior peak by 2025-07-23. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is RAPT's long-term total return over 10, 20, or 30 years?
RAPT Therapeutics, Inc. (RAPT) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -44.3% (-5.7% CAGR) — $10,000 would have grown to $5,575. Over 20 years: -44.3% total return (-2.9% CAGR) — $10,000 → $5,575. Over 30 years: -44.3% total return (-1.9% CAGR) — $10,000 → $5,575. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was RAPT's best and worst year?
RAPT Therapeutics, Inc.'s best calendar year was 2025 with a total return of 159.7%. Its worst year was 2024 with a total return of -93.5%. This range shows the volatility investors should expect — the difference between the best and worst year is 253.2 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).